Microvast's GAAP EPS of $0.05 beat estimates, but adjusted loss of $0.11 and revenue miss of 26.6% reveal underlying weakness…

BW swings to $0.02 EPS vs. $0.05 loss estimate on $161M revenue, missing top-line consensus by 2.5% as margins drive…

Ampco-Pittsburgh reports $2.85 per share loss on $108.8M revenue, matching prior quarter's loss as adjusted EBITDA reaches $3.2M.

Black Diamond Therapeutics posted a narrower-than-expected Q4 loss of $0.14/share but missed revenue estimates with zero sales.

Digimarc swings to Q4 profit of $0.05 per share vs. consensus loss estimate, with revenue of $8.9M topping the $7.0M…

OPAL Fuels missed Q4 EPS estimates by 94.7% at $0.02 vs $0.38 consensus, though revenue topped forecasts at $99.8M on…

W&T Offshore posts $0.37 per share loss, 20.7% wider than estimates, as Q4 revenue reaches $501.5 million against $123.7 million…

Zenas BioPharma, Inc. (ZBIO) reported Q4 2025 GAAP loss of $1.39 per share, a wider loss than the -$1.19 estimate…

Dollar Tree, Inc. (DLTR) turned in Q4 2025 adjusted EPS of $2.56, exceeding the $2.20 Street estimate (beat by 16.4%).

Q4 2025 loss at CytomX Therapeutics, Inc. (CTMX) widened to $0.20 per share GAAP, worse than the -$0.09 estimate (116.4%…